Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 23:15:1268464.
doi: 10.3389/fphar.2024.1268464. eCollection 2024.

Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity

Affiliations
Review

Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity

Xiao-Yan Gao et al. Front Pharmacol. .

Abstract

Scopoletin is a coumarin synthesized by diverse medicinal and edible plants, which plays a vital role as a therapeutic and chemopreventive agent in the treatment of a variety of diseases. In this review, an overview of the pharmacology, pharmacokinetics, and toxicity of scopoletin is provided. In addition, the prospects and outlook for future studies are appraised. Scopoletin is indicated to have antimicrobial, anticancer, anti-inflammation, anti-angiogenesis, anti-oxidation, antidiabetic, antihypertensive, hepatoprotective, and neuroprotective properties and immunomodulatory effects in both in vitro and in vivo experimental trials. In addition, it is an inhibitor of various enzymes, including choline acetyltransferase, acetylcholinesterase, and monoamine oxidase. Pharmacokinetic studies have demonstrated the low bioavailability, rapid absorption, and extensive metabolism of scopoletin. These properties may be associated with its poor solubility in aqueous media. In addition, toxicity research indicates the non-toxicity of scopoletin to most cell types tested to date, suggesting that scopoletin will neither induce treatment-associated mortality nor abnormal performance with the test dose. Considering its favorable pharmacological activities, scopoletin has the potential to act as a drug candidate in the treatment of cancer, liver disease, diabetes, neurodegenerative disease, and mental disorders. In view of its merits and limitations, scopoletin is a suitable lead compound for the development of new, efficient, and low-toxicity derivatives. Additional studies are needed to explore its molecular mechanisms and targets, verify its toxicity, and promote its oral bioavailability.

Keywords: pharmacokinetics; pharmacological activities; plant sources; scopoletin; toxicology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Structure of scopoletin.
FIGURE 2
FIGURE 2
Synthesis of scopoletin (Kai et al., 2008).
FIGURE 3
FIGURE 3
Main biological activities and possible molecular mechanisms of scopoletin.

Similar articles

Cited by

References

    1. Abdullah N. H., Salim F., Ahmad R. (2016). Chemical constituents of Malaysian U. Cordata var. ferruginea and their in vitro α-glucosidase inhibitory activities. Molecules 21 (5), 525. 10.3390/molecules21050525 - DOI - PMC - PubMed
    1. Acharya D., Bogati B., Risal P. (2013). Scopoletin reduces intracellular survival of Salmonella typhi within U937 human macrophage cell line in vitro . Afr. J. Microbiol. Res. 1 (6), 47–51.
    1. Ahmadi N., Mohamed S., Sulaiman Rahman H., Rosli R. (2019). Epicatechin and scopoletin-rich Morinda citrifolia leaf ameliorated leukemia via anti-inflammatory, anti-angiogenesis, and apoptosis pathways in vitro and in vivo . J. Food Biochem. 43 (7), e12868. 10.1111/jfbc.12868 - DOI - PubMed
    1. Ahn M. J., Hur S. J., Kim E. H., Lee S. H., Shin J. S., Kim M. K., et al. (2014). Scopoletin from Cirsium setidens increases melanin synthesis via CREB phosphorylation in B16F10 cells. Korean J. Physiol. Pharmacol. 18 (4), 307–311. 10.4196/kjpp.2014.18.4.307 - DOI - PMC - PubMed
    1. Alkorashy A. I., Doghish A. S., Abulsoud A. I., Ewees M. G., Abdelghany T. M., Elshafey M. M., et al. (2020). Effect of scopoletin on phagocytic activity of U937-derived human macrophages: insights from transcriptomic analysis. Genomics 112 (5), 3518–3524. 10.1016/j.ygeno.2020.03.022 - DOI - PubMed

LinkOut - more resources